5 Best Small-Cap Value Stocks to Buy

4. ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)

Forward P/E: 9.12

Market Cap: $1.93 Billion

Number of Hedge Fund Holders: 41

Stock Upside Potential: 43.30%

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)is one of the best small-cap value stocks to buy. On April 20, ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) confirmed the Food and Drug Administration’s approval of Pimozide Tablets in 1 mg and 2 mg strengths.

Following approval, the company has launched Pimozide tablets, a generic version of the reference listed drug (RLD) Orap. The company has also successfully secured 180-day CGT exclusivity for the drug.

The launch underscores Ani Pharmaceuticals’ focus on bringing to market products with limited competition while offering generic alternatives to customers. Pimozide annual sales in the US total about $3.1 million

The launch of Pimozide tablets comes against the backdrop of the company’s launch of Carbamazepine Extended-Release Capsules in 100 mg, 200 mg, and 300 mg strengths. The launch of the generic version of RLD Carbatrol continues to strengthen the company’s generic portfolio. U.S. annual sales for Carbamazepine Extended-Release Capsules total approximately $65 million.

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) is a diversified biopharmaceutical company that develops, manufactures, and commercializes high-quality branded, generic, and over-the-counter pharmaceuticals. They focus on rare diseases (ophthalmology, oncology) and maintain U.S.-based manufacturing facilities, including specialized capabilities for potent, high-containment products.